Is heme oxygenase-1 a causal player for plaque stability?

Stroke

Volumn 36, Issue 9, 2005, Pages 1901-1903

  Espinola Klein, Christine ^a   Blankenberg, Stefan ^a   Münzel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Carotid arteries; Infection; Inflammation; Stroke

Indexed keywords

CYCLIC GMP; CYTOCHROME P450; HEME OXYGENASE 1; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; STROKE;

EID: 24644456887     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.36.9.1901     Document Type: Note

References (35)

1. Ross R. Atherosclerosis is an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis. Emerging mechanistic paradigms. Circulation. 1999;100:e20-e28.
3. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335-340.
4. Farsak B, Yildirir A, Akyön Y, Pinar A, Öc M, Böke E, Kes S, Tokgözoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000;38:4408-4411.
5. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000;20:1417-1420.
6. Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C. Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005;352:1637-1645.
7. Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene A. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005;352: 1646-1654.
8. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21.
9. Xu Q, Wick G. The role of heat shock protein in protection and pathophysiology of the arterial wall. Mol Med Today. 1996;2:373-379.
10. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufmann SH, Wick G. Induction of atherosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992;12:789-799.
11. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 1999;99:1560-1566.
12. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175-1186.
13. Danesh J, Peto. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ. 1998;316: 250-256.
14. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation. 1998;98:845-850.
15. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-1222.
16. Kurosawa A, Miwa H, Hirose M, Tsune I, Nagahara A, Sato N. Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphyrolated p53, p21 and Bax expression in endothelial cells. J Med Microbiol. 2002;51:385-391.
17. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Geta RM. Cross-reactivity of anti-CagA antibodies with vascular wall antigens. Possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002;106: 430-434.
18. Miinzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of Superoxide in vascular tissue. Arterioscler Thromb Vasc Biol. 2002;22: 1761-1768.
19. Madamanchi NP, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcome. J Thromb Haemost. 2005;3:254-267.
20. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ. Gluathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003;349:1603-1613.
21. Morse D, Choi AM. Heme oxygenase-1: from bench to bedside. Am J Respir Crit Care Med. June 30, 2005 [Epub ahead of print].
22. Duckers HJ, Boehm M, True AL, Yet S-F, San H, Park JL, Webb RC, Lee M-E, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001;7:693-698.
23. Ishikawa K, Sugawara D, Wang X-P, Suzuki K, Itabe H, Maruyama Y, Lusus AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res. 2001;88:506-512.
24. Yet S-F, Layne MD, Liu X, Chen Y-H, Ith B, Sibinga ES, Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 2003;17:1759-1761.
25. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Shoichi K. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999; 103: 129-135.
26. Polte T, Abate A, Dennery PA, Schröder H. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol. 2000;20: 1209-1215.
27. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
28. Amerisio SF, Villamil AR, Zedda C, Parodi JC, Garrido S, Sarchi MI, Schultz M, Boczkowski J, Sevlever GE. Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected by Helicobacter pylori and is more prevalent in asymptomatic subjects. Stroke. 2005;36:1896-1900.
29. De Luca A, Laquinto G. Helicobacter pylori and gastric disease: a dangerous association. Cancer Lett 2004;213:1-10.
30. Kukaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydropterin, ascorbic acid, and thiols: implication for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278: 22546-22554.
31. Zou M, Jendral M, Ullrich V. Prostaglandin endoperioxide-dependent vasospasm in bovine coronary arteries nitration prostacycline synthase. Br J Pharmacol. 1999;126:1283-1292.
32. Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334.
33. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev. 2000;8:31-39.
34. Patel P, Mendall MA, Carrington D, Strahan DP, Leatham E, Molineaux N, Levey J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infection with coronary artery disease and cardiovascular risk factors. BMJ. 1995; 311:711-714.
35. Lamb DJ, El-Sankary W, Ferns GAA. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunization. Atherosclerosis. 2002;167:177-185.